Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ABVC, Akeso, Ascentage, Astrazeneca, Daiichi Sankyo, Eli Lilly, Inflarx, Innovent Biologics, Jiangsu Recbio Technology, Kyowa Kirin, Pfizer, Prestige, Sinovac, Skye, Unibio Science, Valneva.